Enabling New Pharma: Drug Re-purposing Efforts Go Mainstream. Innovative Alternatives for Stalled Pharmaceutical Pipelines Rathnam Chaguturu, SRI International, speaking at Drug Discovery and Development 2014
Science for Life Laboratory Drug Discovery & Development Platform Per Arvidson, Karolinska Institute, speaking at Drug Discovery and Development 2014
Characterizing the Early Drug Development Outsourcing Landscape Stella Stergiopoulos, Tufts Center for the Study of Drug Design, speaking at Drug Discovery and Development 2014
ETP Nanomedicine and NANOMED2020: Towards a New Nanomedicine Horizon Olivier Fontaine, Nanobiotix, speaking at Nanomedicine 2014.
Challenges of Implementing and Validating CTC Assays in Oncology Clinical Trials Iman Jilani, Pfizer, speaking at Exosomes and Circulating Biomarkers Summit 2013.
Biomarker Development to Improve Trials for Type 1 Diabetes Professor Matthias von Herrath, The La Jolla Institute for Allergy and Immunology, speaking at Exosomes and Circulating Biomarkers Summit 2013.
Companion Diagnostics Development at the Siemens Clinical Laboratory Sunil Pandit, Siemens Healthcare Diagnostics, speaking at Exosomes and Circulating Biomarkers 2013.
Esoteric Diagnostics in China: A Case Review of Building up the First and Largest Esoteric Laboratory Network in China Shiang Huang, Kindstar Global, speaking at Point-of-Care Diagnostics World Congress 2013.
Companies in Translation with CIRM Dr Alan Trounson, California Institute for Regenerative Medicine, speaking at Stem Cells 2012